Search Results - "Bakker, A.M."

Refine Results
  1. 1

    Characterization and standardization of Sabin based inactivated polio vaccine: Proposal for a new antigen unit for inactivated polio vaccines by Westdijk, Janny, Brugmans, Debbie, Martin, Javier, Oever, Aart van’t, Bakker, Wilfried A.M, Levels, Lonneke, Kersten, Gideon

    Published in Vaccine (18-04-2011)
    “…Abstract GMP-batches of Sabin-IPV were characterized for their antigenic and immunogenic properties. Antigenic fingerprints of Sabin-IPV reveal that the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Development of inactivated poliovirus vaccine from Sabin strains: A progress report by Okayasu, Hiromasa, Sein, Carolyn, Hamidi, Ahd, Bakker, Wilfried A.M., Sutter, Roland W.

    Published in Biologicals (01-11-2016)
    “…The Global Polio Eradication Initiative (GPEI) has seen significant progress since it began in 1988, largely due to the worldwide use of oral poliovirus…”
    Get full text
    Journal Article
  5. 5

    Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak by Winter, Manon J, Nagelkerken, Bas, Mertens, Alexander E.E, Rees-Bakker, Hellen A.M, Briaire-de Bruijn, Inge H, Litvinov, Sergey V

    Published in Experimental cell research (15-04-2003)
    “…Various adhesion molecules play an important role in defining cell fate and maintaining tissue integrity. Therefore, cross-signaling between adhesion receptors…”
    Get full text
    Journal Article
  6. 6

    Development of an animal component free production process for Sabin inactivated polio vaccine by Suarez-Zuluaga, Diego A., van der Pol, Leo A., van 't Oever, Aart G., Bakker, Wilfried A.M., Thomassen, Yvonne E.

    Published in Vaccine: X (01-12-2022)
    “…Inactivated polio vaccine production using attenuated Sabin strains (sIPV) instead of wild type polio viruses (cIPV) is an initiative encouraged by the World…”
    Get full text
    Journal Article
  7. 7

    Kinetic model for adherent Vero cell growth and poliovirus production in batch bioreactors by Jiang, Yang, van der Welle, Joyce E., Rubingh, Olaf, van Eikenhorst, Gerco, Bakker, Wilfried A.M., Thomassen, Yvonne E.

    Published in Process biochemistry (1991) (01-06-2019)
    “…[Display omitted] •Mathematical model for Vero cell growth in batch bioreactors.•Mathematical model for poliovirus proliferation on Vero cells.•Oxygen uptake…”
    Get full text
    Journal Article
  8. 8

    sIPV process development for costs reduction by Thomassen, Yvonne E, Bakker, Wilfried A.M

    Published in Vaccine (20-08-2015)
    “…Abstract Polio is expected to be eradicated within only a few years from now. Upon polio eradication, the use of oral polio vaccines, which can cause…”
    Get full text
    Journal Article
  9. 9

    Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants by Verdijk, Pauline, Rots, Nynke Y, van Oijen, Monique G.C.T, Weldon, William C, Oberste, M. Steven, Okayasu, Hiromasa, Sutter, Roland W, Bakker, Wilfried A.M

    Published in Vaccine (03-09-2014)
    “…Abstract Background An inactivated poliovirus vaccine (IPV) based on attenuated poliovirus strains (Sabin-1, -2 and -3) was developed for technology transfer…”
    Get full text
    Journal Article
  10. 10

    Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell-Cell Interactions Mediated by Classic Cadherins by Litvinov, Sergey V., Balzar, Maarten, Winter, Manon J., Hellen A. M. Bakker, Briaire-de Bruijn, Inge H., Prins, Frans, Fleuren, Gert Jan, Warnaar, Sven O.

    Published in The Journal of cell biology (01-12-1997)
    “…The contribution of noncadherin-type, Ca2+-independent cell-cell adhesion molecules to the organization of epithelial tissues is, as yet, unclear. A…”
    Get full text
    Journal Article
  11. 11

    Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains by Westdijk, Janny, Koedam, Patrick, Barro, Mario, Steil, Benjamin P, Collin, Nicolas, Vedvick, Thomas S, Bakker, Wilfried A.M, van der Ley, Peter, Kersten, Gideon

    Published in Vaccine (18-02-2013)
    “…Highlights ► Six adjuvants with Sabin inactivated poliovirus vaccine were evaluated in rats. ► The increase of neutralizing antibodies was 3-, 15-, 24-fold for…”
    Get full text
    Journal Article
  12. 12

    Improved poliovirus d -antigen yields by application of different Vero cell cultivation methods by Thomassen, Yvonne E, Rubingh, Olaf, Wijffels, René H, van der Pol, Leo A, Bakker, Wilfried A.M

    Published in Vaccine (19-05-2014)
    “…Highlights • Vero cells were grown in batch, semi-batch, perfusion and recirculation strategies. • At high cell densities (to 5 × 106 cells mL−1 ) cells were…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14

    Assessment of mass transfer and mixing in rigid lab-scale disposable bioreactors at low power input levels by van Eikenhorst, Gerco, Thomassen, Yvonne E., van der Pol, Leo A., Bakker, Wilfried A. M.

    Published in Biotechnology progress (01-11-2014)
    “…Mass transfer, mixing times and power consumption were measured in rigid disposable stirred tank bioreactors and compared to those of a traditional glass…”
    Get full text
    Journal Article
  15. 15

    Scale-down of the inactivated polio vaccine production process by Thomassen, Yvonne E., van 't Oever, Aart G., Vinke, Marian, Spiekstra, Arjen, Wijffels, René H., van der Pol, Leo A., Bakker, Wilfried A.M.

    Published in Biotechnology and bioengineering (01-05-2013)
    “…The anticipated increase in the demand for inactivated polio vaccines resulting from the success in the polio eradication program requires an increase in…”
    Get full text
    Journal Article
  16. 16

    Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: A phase I trial in healthy adults by Verdijk, Pauline, Rots, Nynke Y, van Oijen, Monique G.C.T, Oberste, M. Steven, Boog, Claire J, Okayasu, Hiromasa, Sutter, Roland W, Bakker, Wilfried A.M

    Published in Vaccine (12-11-2013)
    “…Highlights • Both Sabin-IPV and Sabin-IPV adjuvanted with aluminum hydroxide are well-tolerated. • A booster with Sabin-IPV or adjuvanted Sabin-IPV is equally…”
    Get full text
    Journal Article
  17. 17

    A mucosal adjuvant for the inactivated poliovirus vaccine by Steil, Benjamin P, Jorquera, Patricia, Westdijk, Janny, Bakker, Wilfried A.M, Johnston, Robert E, Barro, Mario

    Published in Vaccine (23-01-2014)
    “…Highlights • GVI 3000 adjuvant increased the potency of IPV in mice. • Systemic and mucosal immune responses to IPV were increased in mice. • IPV + GVI3000…”
    Get full text
    Journal Article
  18. 18

    Comparison of initial feasibility of host cell lines for viral vaccine production by Vlecken, Danielle H.W., Pelgrim, Ralf P.M., Ruminski, Slawomir, Bakker, Wilfried A.M., van der Pol, Leo A.

    Published in Journal of virological methods (01-10-2013)
    “…•Virus host cells compared.•Serum interference and viral replication.•HPV receptor expression. In order to reduce the time required for the development and…”
    Get full text
    Journal Article
  19. 19

    Multivariate data analysis on historical IPV production data for better process understanding and future improvements by Thomassen, Yvonne E, van Sprang, Eric N.M, van der Pol, Leo A, Bakker, Wilfried A.M

    Published in Biotechnology and bioengineering (01-09-2010)
    “…Historical manufacturing data can potentially harbor a wealth of information for process optimization and enhancement of efficiency and robustness. To extract…”
    Get full text
    Journal Article
  20. 20

    Mathematical model of adherent Vero cell growth and poliovirus production in animal component free medium by Ursache, Ramona V., Thomassen, Yvonne E., van Eikenhorst, Gerco, Verheijen, Peter J. T., Bakker, Wilfried A. M.

    Published in Bioprocess and biosystems engineering (01-03-2015)
    “…Sabin–IPV (or sIPV, inactivated polio vaccine based on attenuated Sabin strains) is anticipated to replace the oral polio vaccine for the endgame in polio…”
    Get full text
    Journal Article